Belgium· BE-AMP-SAM217287-00

Cefazoline Sandoz 2 g

A cefazolin product containing cefazolin sodium, registered in Belgium by Sandoz. The same ATC class is registered in 18 of our 19 countries.

ATC J01DB04

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cefazolin sodiumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cefazolin is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DB04 (cefazolin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
11 of them publish a price we can compare per daily dose

Search cefazolin products by name

Cefazolin · ATC J01DB04

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefazolin costs, country by country.

Normalised to the WHO defined daily dose (3 g), the median price runs from $8.27 in Spain to $16.85 in Switzerland — a ×2.0 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cefazolin · price per daily dose (3 g)

USD · FX 28 Sept 2026

CH Switzerland$16.85
ES Spain$8.27

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Cefazolin Sodium
Manufacturer: Sandoz
Country: Belgium (BE)
ATC code: J01DB04
ATC class: Cefazolin
Defined daily dose: 3 g, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 1

be_apb
2218188

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

166 interactions on record for cefazolin.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cefazolin against other medicines How interaction checks work

Cefazolin · interactions on record

166 records

20 moderate
2 minor
144 info

Most severe, free to view

Sodium picosulfateA06AB08moderate
NeomycinA07AA01moderate
StreptomycinA07AA04moderate
KanamycinA07AA08moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefazolin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefazolin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Cefazolin Aptapharma, Cefazolin Mip
Bulgaria · Зепилен, Золибиотик
Cyprus · Cefazolin Codal-Synto, Cefazolin Noridem
Czechia · Azepo, Cefazolin Aptapharma
Germany · Cefazolin Dali Pharma, Cefazolin Dr. Eberth
Denmark · Cefazolin Mip, Cefazolin Noridem
Estonia · Cefazolin Mip, Zepilen
Spain · Cefazolina Iv Normon, Cefazolina Ldp-Laboratorios Torlan
Finland · Cefazolin Mip Pharma
France · Cefazoline Basi, Cefazoline Noridem
United Kingdom (Northern Ireland) · Cefazolin Acs Dobfar, Cefazolin Mip Pharma
Greece · Cefazolin Demo, Cefazolin/Demo
Croatia · Cefazolin Alpha-Medical, Cefazolin Aptapharma
Hungary · Cefazolin Aptapharma, Cefazolin Panpharma
Iceland · Cefazolin Normon, Kefzol
Italy · Cefazil, Cefazolina Git
Lithuania · Cefazolin Mip, Rezol
Luxembourg · Cephazolin Fresenius
Latvia · Cefazolin Bcpp, Cefazolin Mip
Malta · Cefazolin Medochemie, Cefazolin Pharmsol
Netherlands · Cefazoline Hameln, Cefazoline Mylan
Norway · Cefazolin Mip, Cefazolin Navamedic
Poland · Biofazolin, Cefazolin Aptapharma
Portugal · Cefazolina Basi, Cefazolina Im Hikma
Romania · Cefazolină Aptapharma, Cefazolina Atb
Sweden · Cefazolin Mip, Cefazolin Noridem
Slovenia · Cefamezin, Cefazolin Aptapharma
Slovakia · Cefazolin Aptapharma, Cefazolin Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d6922df1-6324-4fda-81af-452065f89e0b
GET /v1/drugs/d6922df1-6324-4fda-81af-452065f89e0b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Cefazoline Sandoz 2 g",
  "name_fr": "Cefazoline Sandoz 2 g",
  "name_nl": "Cefazoline Sandoz 2 g",
  "amp_code": "SAM217287-00",
  "strengths": [
    "2096.0000",
    "2000.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Cefazolin Sodium",
    "Cefazolin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cefazolin",
  "authorisation_numbers": [
    "BE217287"
  ]
}

API reference MCP server Plans

See everything about cefazolin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console